Evidence map›Paper›PMID 35745023›Full record

ReviewMolecules (Basel, Switzerland)2022

The Effectiveness of

Emilija Ivanova Stojcheva, José Carlos Quintela

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. The effect ofFrontiers in nutrition · 2025
    Pooled it
  3. Effects ofNutrients · 2026
    Trial
  4. Trial
  5. The Effect of Short-TermNutrients · 2025
    Trial
  6. Can Rhodiola rosea supplementation mitigate digital eye strain? A triple-blinded placebo-controlled study.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Trial
  7. Trial
  8. Antioxidant Properties of aLife (Basel, Switzerland) · 2026
    Article
  9. Review
  10. Article
  11. Nanoencapsulation ofRSC advances · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Development of Orally Disintegrating Tablets of StandardizedPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emilija Ivanova StojchevaNatac Biotech S.L., 28923 Madrid, Spain.
José Carlos QuintelaNatac Biotech S.L., 28923 Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Plants, MedicinalRhodiolaFatigueHumansMalePlant ExtractsStress, PsychologicalPlant Extractsadaptogenclinical studiesgolden rootmedicinal plantsphytotherapyRhodiola rosearoserootstress protection

Identifiers

PMID35745023
PMCPMC9228580
OpenAlexW4283065659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.